Recent findings have shown that Proteobacteria can directly consume arginine, thereby reducing its systemic availability and impairing anti-tumor immunity by enhancing Treg suppressive activity and dampening CD8+ T cell responses (76). The gene discussed is CD8A; the disease is neoplasm.